Lee Doyeon, Heo Yoseob, Kim Keunhwan
Division of Data Analysis, Korea Institute of Science and Technology Information (KISTI), Seoul 02456, Korea.
Busan Branch, Division of Data Analysis, Korea Institute of Science and Technology Information (KISTI), Busan 48058, Korea.
Healthcare (Basel). 2020 Jul 9;8(3):204. doi: 10.3390/healthcare8030204.
The coronavirus crisis may lead to a deeper understanding of international collaborations for developing antivirals and vaccines that are essential to protect us from current and future health security threats. Beyond technical solutions, the government of South Korea needs to establish a timely strategic investment in coronavirus-related research and development (R&D) in order to enhance the capabilities for managing this new uncertainty in regard to the domestic health crisis. Thus, this study aims to provide useful information about the status of global coronavirus-related research from the South Korean government's perspective. National funded projects stemmed from leading nations such as the United States, countries of the European Union, and Japan between 2012 and 2018. Six research fields were derived by clustering analysis and an expert-based approach, and then matched to those of South Korea. The comparative analysis among them allowed for the identification of the nations' strengths and weaknesses, thereby laying the groundwork for strategic international research collaborations.
冠状病毒危机可能会使人们更深入地理解国际合作在开发抗病毒药物和疫苗方面的作用，而这些对于保护我们免受当前和未来的健康安全威胁至关重要。除了技术解决方案，韩国政府需要对冠状病毒相关的研发进行及时的战略投资，以增强应对国内健康危机这种新不确定性的能力。因此，本研究旨在从韩国政府的角度提供有关全球冠状病毒相关研究现状的有用信息。2012年至2018年间，国家资助项目来自美国、欧盟国家和日本等主要国家。通过聚类分析和基于专家的方法得出了六个研究领域，然后将其与韩国的研究领域进行匹配。对它们之间的比较分析有助于识别各国的优势和劣势，从而为战略性国际研究合作奠定基础。
